Sara Bell (@SaraFEBell) header
Sara Bell (@SaraFEBell) profile picture

#PhD student @MicroDx_UQ #UQCCR @UQMedicine Molecular diagnostics utility #AMR #gonorrhoea #publichealth Views my own. she/they 🇬🇧🇦🇺🏳️‍🌈🏳️‍⚧️

Meanjin (Brisbane), Australia
Joined September 2018
Photo by Sara Bell (@SaraFEBell)Photo by Sara Bell (@SaraFEBell)Photo by Sara Bell (@SaraFEBell)Photo by Sara Bell (@SaraFEBell)Photo by Sara Bell (@SaraFEBell)Photo by Sara Bell (@SaraFEBell)Photo by Sara Bell (@SaraFEBell)
Excited to share my latest publication discussing the utility of #neisseria #gonorrhoea molecular antimicrobial susceptibility assays to guide individualised resistance-guided treatment! @MicroDx_UQ #UQCCR @UQMedicine @theamrhub doi.org/10.1016/S2666-5247(2…
5
13
24
2,464
Employment opportunity: Senior Staff Specialist or Staff Specialist - Sexual Health Medicine, Brisbane. Closing date Wednesday 28 May 2025 smartjobs.qld.gov.au/jobs/QL…
51
📢 The Journal of Medical Microbiology is looking for Editors for the Antimicrobial Resistance section! No prior editor experience required, so it's a great first gig for an ECR. And you get subsidised attendance at the annual meeting. Open to applicants worldwide🌍 @MicrobioSoc
4
18
1,246
Receipt of doxyPEP was associated with substantial declines in chlamydia and syphilis incidence and modest declines in urethral and rectal gonorrhea incidence among individuals using HIV PrEP. ja.ma/41VQmVQ
6
1
11
11,317
Sara Bell retweeted
#UQ research shows high-income Australian communities are big users of antimicrobials, like antibiotics and hand sanitisers. While they can help fight bacteria and viruses, overuse may actually reduce their effectiveness. @uqhealth brnw.ch/21wPdZe
3
1
1,036
We at the Hub are very excited to launch the Pull Incentives Gallery on our #DynamicDashboard! 💻 Want to know where Pull Incentives are being planned or used, how they work, and the approaches being taken? Explore the new Gallery today: dashboard.globalamrhub.org/r…
1
4
14
538
Sara Bell retweeted
Media has a fundamental role to play to stop rape culture. All of us can also help by changing the narrative that places blame on victims and using the power of language in service of survivors, not perpetrators. More from @UN_Women: unwomen.org/en/get-involved/… #16days
150
259
29
443
86,235
Generosity rarely starts with an offer of help. It often begins with a question about what others need. Even those close to us face invisible hardships. The best way to give is to ask about their challenges. We don't always have a solution, but we can always make them feel seen. #GivingTuesday
64
588
49
2,278
146,370
After going to 4 stores and asking an employee to unlock a cabinet, I bought the @nowdx1 syphilis test! It’s an exciting time to be able to buy an OTC syphilis test but inequities with access remain and it’s imperative that the STI community find new ways to expand access.
3
1
11
475
If you have an interest in infectious disease, AMR, clinical trials or genomics - we have a PhD scholarship available for a suitable candidate. Alas only eligible for Australian domestic applicants @UQMedicine @MerinoTrial @UQ_GAMECHANGER study.uq.edu.au/study-option…
8
12
1,059
🎉Congratulations to our researchers, Professors Kit Fairley, Catriona Bradshaw, and Eric Chow, for being named among the world's top 2% scientists in the 2024 Standard's List @kitfairley @DrCatBradshaw @EricPFChow @AlfredHealth @MonashSTM @Monash_FMNHS
1
3
1
15
1,084
“Australians are being urged to get regular tests for sexually transmitted infections (STIs) after a significant rise in cases across the country, including an almost 20% increase in New South Wales gonorrhoea cases between 2022 and 2023.” ow.ly/6wfU50T74jL
2
2
119
So excited to be able to finally share this amazing work! 🤓
NEW ARTICLE!🚨 A murine🐁model of #Neisseria male genital infection 🦠demonstrating the utility of Neisseria musculi, a novel mouse strain, to enhance our understanding of #gonorrhoea infections in men! ♂️ #UQCCR @UQMedicine @EmilyBryanPhD @ScienceNerdEmma @Jake_T_PhD @theamrhub
2
8
412
Thanks @BenchSideStory for the opportunity to chat! #breastcancer #uqccr @UQMedicine
INVESTIGATING INVASIVE LOBULAR CARCINOMA AND METAPLASTIC BREAST CANCER SUB-TYPES RESEARCHER PROFILE Associate Professor Amy McCart Reed (Filmed June 2024) Senior Principal Research Fellow, Centre for Clinical Research @UQCC University of Queensland @UQ_News Australia Associate Professor Amy McCart Reed holds a PhD in molecular biology from The University of Queensland. She is a Fellow of the Faculty of Science of the Royal College of Pathologists Australasia @PathologyRCPA . Her early postdoctoral work focused on understanding the genetic basis of colorectal cancer using experimental disease models, as part of a Cancer Research UK-funded colorectal cancer program led by Professors Ian Tomlinson and Andrew Silver. After returning to Australia, she was recruited to the Molecular Breast Pathology group at UQ’s Centre for Clinical Research and has undertaken a series of studies investigating the genomic landscape of breast cancer special types. Amy's research program includes studies on Metaplastic breast cancer and Invasive Lobular Carcinoma, two breast cancer special types in need of targeted therapy options. Assoc Prof McCart Reed is the scientific lead on an MRFF-funded (Medical Research Future Fund) genomics program investigating the potential for the application of Whole Genome Sequencing in the breast cancer care pathway in Australia, 'Q-IMPROvE'. She applies genomics and spatial transcriptomics methodologies to archival clinical samples to understand the differences between tumour types and their potential for treatment. Amy is passionate about clinical research, biobanking and precision oncology. In addition to her breast cancer research portfolio, she is on the steering committee for the Brisbane Breast Bank and the Scientific Advisory Board for Breast Cancer Trials @BCTrialsANZ. SEE OTHER RESEARCHER PROFILES Bench Side Story @BenchSideStory benchsidestory.com
1
6
21
850
BLING-3 results in 10hrs… Does continuous infusion of beta-lactam antimicrobials decrease day 90 mortality in sepsis. >7000 patients and >100 ICUs providing data to the trial and all summarised in a SRMA. Livestream criticalcarereviews.com
4
23
4
80
16,695
We are recruiting a lead genomic / digital epidemiologist to help drive analytics and health system strengthening for genomic epi in LMICs (as part of the NIHR Global Health Research Unit on Genomic surveillance of AMR) - come join a fantastic team! my.corehr.com/pls/uoxrecruit…
16
1
28
3,437